Benign positional vertigo Market Share

Benign Positional Vertigo Market Overview

The Benign Positional Vertigo market is expected to reach USD 1.9 Billion at a CAGR 4.1% during the forecast period 2023-2032. Benign Positional Vertigo Market Benign Positional Vertigo or Benign paroxysmal positional vertigo (BPPV) is disorder related to inner ear. Vertigo is feeling of spinning or everything is spinning around. Increasing number of cases of benign positional disorder is the major factor for the market growth. New treatments and product development are also key driving forces for the benign positional vertigo market. Increasing awareness of the disorder and treatment options are leading the market growth. Medicine, devices and accessories manufacturers are developing new products for the market. Moreover, increasing funding for R&D of advanced product development are major drivers for the market.

Study objectives of Benign Positional Vertigo Market

• To provide detailed analysis of the benign positional vertigo market structure with historical and forecast revenue for the next 7 years of the various segments and sub-segments of the benign positional vertigo market


• To provide insights about the key drivers, restraints, opportunities and challenges that affecting the growth of the benign positional vertigo market


• To provide analysis of the market with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.


• To provide detail analysis of the market that segmented on the basis of type, by diagnosis, by treatment, and its sub-segments.


• To provide detail analysis of benign positional vertigo market mainly based on value chain analysis, Porter’s five forces, Price analysis, and Supply Chain analysis etc.


• To provide detail country level analysis of the market with respect to the current market size and future prospective


• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the benign positional vertigo Market


• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the benign positional vertigo market

Benign Positional Vertigo Market Key Competitors

Some of the key players in this market are: 

• Ambu A/S (Denmark), 


• DizzyFix (Canada), 


• DizzyStop (US), 


• Dr. Reckeweg & Co. GmbH (Germany), 


• Ocean Global (U.K.), 


• Vertisil (US), 


• SIDIS LABS LLC (US), 


• and Others

Benign Positional Vertigo Market Segment Insights

Benign Positional Vertigo Type Insights      

Benign positional vertigo Market has been segmented on the basis of type which Benign, Paroxysmal, Positional, Vertigo, and others. 

Benign Positional Vertigo Diagnosis Insights

On the basis of diagnosis, it is segmented into Electroencephalogram (EEG), Electronystagmography (ENG), Head CT, Head MRI, Hearing test, Magnetic resonance angiography, Caloric stimulation, and others. 

Benign Positional Vertigo Treatment Insights

On the basis of treatment, the market is segmented into Canalith repositioning (sub-segmented into Semont-Toupet Maneuver, Epley Maneuver), Surgery (Posterior Canal Plugging, Laser assisted posterior canal plugging), medication (Antihistamines, Scopolamine, Sedatives), and others.

Benign Positional Vertigo Market Regional Analysis    

Considering the global scenario of the market, due to continuous innovation and rapid adoption of new drugs and therapies, Americas is largest market for benign positional vertigo. US is holding largest market share in Americas region. European market is second largest, and especially the growth rate is higher in Western European countries. On the other hand, due increasing knowledge of disease and treatments, developing healthcare infrastructure, and increasing healthcare spending, the Asia-Pacific (APAC) is fastest growing market for benign positional vertigo and expected to grow significantly during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of devices and treatment. 

Intended Audience

• Benign positional vertigo medicines and devices manufacturers


• Benign positional vertigo medicines and devices providers


• Hospitals and clinics


• Medical Research laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors